Prognosis in patients with cirrhosis and mild portal hypertension

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 12, 2006, Pages 1446-1453

  Ytting, Henriette ^a   Møller, Søren ^a   Henriksen, Jens Henrik ^a   Larsen, Klaus ^a   Bendtsen, Flemming ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Hepatic encephalopathy; Oesophageal varices; Portal hypertension; Prognosis; Variceal bleeding

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ANAMNESIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMAN; INFORMATION PROCESSING; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; REGISTER; RISK; SURVIVAL; SURVIVAL RATE;

ADULT; AGED; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVORS;

EID: 33751095920     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600735720     Document Type: Article

References (47)

1. Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, et al. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003;37:902-8.
2. Bosch J, Mastai R, Kravetz D, Navasa M, Rodes J. Hemodynamic evaluation of the patient with portal hypertension. Semin Liver Dis 1986;6:309-17.
3. Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346:1056-9.
4. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5:419-24.
5. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401-7.
6. Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000;32:930-4.
7. Odelowo OO, Smoot DT, Kim K. Upper gastrointestinal bleeding in patients with liver cirrhosis. J Natl Med Assoc 2002;94:712-5.
8. Pinto HC, Abrantes A, Esteves AV, Almeida H, Correia JP. Long-term prognosis of patients with cirrhosis of the liver and upper gastrointestinal bleeding. Am J Gastroenterol 1989;84:1239-43.
9. Zoli M, Cordiani MR, Marchesini G, Iervese T, Labate AM, Bonazzi C, et al. Prognostic indicators in compensated cirrhosis. Am J Gastroenterol 1991;86:1508-13.
10. Kleber G, Sauerbruch T, Ansari H, Paumgartner G. Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study. Gastroenterology 1991;100:1332-7.
11. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-9.
12. Le Moine O, Hadengue A, Moreau R, Sogni P, Soupison T, Yang S, et al. Relationship between portal pressure, oesophageal varices, and variceal bleeding on the basis of the stage and cause of cirrhosis. Scand J Gastroenterol 1997;32: 731-5.
13. Escorsell A, Bordas JM, Castaneda B, Llach J, Garcia-Pagan JC, Rodes J, et al. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension. Hepatology 2000;31: 1061-7.
14. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22: 332-54.
15. Abraczinskas DR, Ookubo R, Grace ND, Groszmann RJ, Bosch J, Garcia-Tsao G, et al. Propranolol for the prevention of first oesophageal variceal hemorrhage: a lifetime commitment? Hepatology 2001;34:1096-102.
16. Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology 1997;25:63-70.
17. Bosch J. Prevention of variceal rebleeding: endoscopes, drugs, and more. Hepatology 2000;32:660-2.
18. De BK, Sen S, Biswas PK, Sengupta D, Biswas J, Santra A, et al. Propranolol in primary and secondary prophylaxis of variceal bleeding among cirrhotics in India: a hemodynamic evaluation. Am J Gastroenterol 2000;95:2023-8.
19. Garcia-Pagan JC, Bosch J. Medical treatment of portal hypertension. Baillieres Best Pract Res Clin Gastroenterol 2000;14:895-909.
20. Gluud C, Henriksen JH, Nielsen G. Prognostic indicators in alcoholic cirrhotic men. Hepatology 1988;8:222-7.
21. Moller S, Bendtsen F, Christensen E, Henriksen JH. Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding. J Hepatol 1994;21: 940-6.
22. Vorobioff J, Groszmann RJ, Picabea E, Gamen M, Villavicencio R, Bordato J, et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology 1996;111:701-9.
23. de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001; 5:645-63.
24. Moller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology 1995; 109:1917-25.
25. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-8.
26. World Health Organisation. International Center for Disease Classification 8th revision (ICD-8). 8th ed. Geneva: 1974.
27. World Health Organisation. International Center for Disease Classification 10th revision (ICD-10). 10th ed. Geneva: 1994.
28. Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull 1999;46:354-7.
29. Bendtsen F, Skovgaard LT, Sorensen TI, Matzen P. Agreement among multiple observers on endoscopic diagnosis of oesophageal varices before bleeding. Hepatology 1990;11: 341-7.
30. Gluud C. Serum testosterone concentrations in men with alcoholic cirrhosis: background for variation. Metabolism 1987;36:373-8.
31. R Foundation for Statistical Computing. R: A language and environment for statistical computing. Vienna, Austria: 2004.
32. Andersen PK, Borgan O, Gill RD, Keiding N. Statistical models based on counting processes. New York: Springer Verlag; 1993.
33. Bendtsen F, Henriksen JH, Sorensen TI. Long-term effects of oral propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis and oesophageal varices. Scand J Gastroenterol 1991;26:933-9.
34. Garcia-Pagan JC, Salmeron JM, Feu F, Luca A, Gines P, Pizcueta P, et al. Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis. Hepatology 1994;19:1095-9.
35. Nevens F, Lijnen P, VanBilloen H, Fevery J. The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites. Hepatology 1996;23:1047-52.
36. Sugano S, Suzuki T, Nishio M, Makino H, Okajima T. Chronic splanchnic hemodynamic effects of low-dose transdermal nitroglycerin versus low-dose transdermal nitroglycerin plus spironolactone in patients with cirrhosis. Dig Dis Sci 1997;42:529-35.
37. Viallet A, Marleau D, Huet M, Martin F, Farley A, Villeneuve JP, et al. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology 1975;69:1297-300.
38. Keiding S, Vilstrup H. Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis. Scand J Gastroenterol 2002;37:960-4.
39. Arroyo V, Bosch J, Gaya-Beltran J, Kravetz D, Estrada L, Rivera F, et al. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Intern Med 1981;94:198-201.
40. Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001; 34:46-52.
41. Gines P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987;7:122-8.
42. Merkel C, Bolognesi M, Bellon S, Zuin R, Noventa F, Finucci G, et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and oesophageal varices. Gastroenterology 1992;102:973-9.
43. Merkel C, Zoli M, Siringo S, van Buuren H, Magalotti D, Angeli P, et al. Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index. Am J Gastroenterol 2000;95:2915-20.
44. Tage-Jensen U, Henriksen JH, Christensen E, Widding A, Ring-Larsen, Christensen NJ. Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis. J Hepatol 1988;6:350-8.
45. Vinel JP, Cassigneul J, Louis A, Levade M, Pascal JP. Clinical and prognostic significance of portohepatic gradient in patients with cirrhosis. Surg Gynecol Obstet 1982;155: 347-52.
46. Vinel JP, Cassigneul J, Levade M, Voigt JJ, Pascal JP. Assessment of short-term prognosis after variceal bleeding in patients with alcoholic cirrhosis by early measurement of portohepatic gradient. Hepatology 1986;6:116-7.
47. Ripoll C, Banares R, Rincon D, Catalina MW, Lo Iacono O, Salcedo M, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology 2005;42: 793-801.